Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,011,567
+$633,994 QoQ
Shares Held
70,739
+141.5% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 188 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. EYPT ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in EYPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,011,567 | 70,739 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $377,573 | 29,292 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,612,984 | 88,286 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,904,557 | 133,747 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,209,542 | 128,538 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,472,131 | 271,611 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $259,200 | 34,792 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $155,820 | 19,502 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $655,134 | 75,303 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,466,990 | 70,972 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $208,659 | 9,029 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $66,237 | 8,290 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $112,873 | 12,974 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $14,114 | 4,801 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $1,866 | 236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,005 | 509 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $105,328 | 8,669 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $194,627 | 15,901 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $614,238 | 58,948 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,220 | 2,583 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,800 | 2,441 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $15,738 | 2,392 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $72,899 | 140,195 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $107,487 | 141,432 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $201,788 | 197,833 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||